当前位置： 阿仪网 > 上海富衡生物科技有限公司 > 产品展示 > 细胞库 > 人源细胞 > 人肺癌细胞A549FH0045
人肺癌细胞A549FH0045
价格：￥电议
品牌名称：富衡型号：FH0045 原产地：中国大陆 更新时间：2026/11/8 9:11:52
产品摘要：A549 细胞系是一种经典的人肺癌细胞系，其组织来源为人类肺腺癌（Adenocarcinoma of the Lung）肿瘤组织。该细胞系由美国典型培养物保藏中心（ATCC）于 1972 年从一名 58 岁男性肺腺癌患者的胸腔积液中分离建立，现广泛应用于肺癌研究、药物开发及分子机制探讨。
店铺主推品 热销潜力款
支付方式：
- 支付宝 微信 银行转账
产品完善度： 访问次数：802
企业档案
会员类型：旗舰版
已获得阿仪网信誉 等级评定
61成长值
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
阿仪网旗舰版会员：3年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
参观次数：742967
详细内容
| 产品名称 | 人肺癌细胞；A549 (STR) |
|---|---|
| 品牌 | FuHeng |
| 英文名 | A549 (STR) |
| 货号 | FH0045 |
| 规格 | 1×10⁶cells/T25培养瓶 |
| 价格 | 1200.0 |
| 培养 | F-12K+10%FBS |
| 别称 | A 549; A549; NCI-A549; A549/ATCC; A549 ATCC; A549ATCC; hA549 |
| 形态特征 | 上皮样；多角形 |
| 生长特性 | 贴壁生长 |
| 培养条件 | 气相：空气，95%；CO2,5%温度：37℃ |
| 传代方法 | 1:2,3天内可长满 |
| 组织来源 | 肺腺癌肿瘤 |
| 细胞简介 | A549 细胞系是一种经典的人肺癌细胞系，其组织来源为人类肺腺癌（Adenocarcinoma of the Lung）肿瘤组织。该细胞系由美国典型培养物保藏中心（ATCC）于 1972 年从一名 58 岁男性肺腺癌患者的胸腔积液中分离建立，现广泛应用于肺癌研究、药物开发及分子机制探讨。 |
| 特征特性 | 该细胞系是1972年由GiardDJ通过肺癌组织移植培养建系的，源自一位58岁的白人男性。A549能通过胞苷二磷脂酰胆碱途径合成富含不饱和脂肪酸的卵磷脂；角蛋白阳性。 |
| 培养基 | A549完全培养基 |
富衡相关文献
| 论文标题 | DOI | 发表时间 | 期刊 | 影响因子 | 作者列表 |
| ZnS/Au Composites Advance Comprehensive Characterization of Low-Molecular-Weight Compounds Toward Pharmaceutical Analysis of Traditional Chinese Medicine | 10.1002/adfm.202525256 | 2026-01-16 | ADVANCED FUNCTIONAL MATERIALS | 19.0 | Wei Chen, Minjia Niu, Xvelian Li, Shouzhi Yang, Ruimin Wang, Wanshan Liu, Fanyu Meng, Yan Zhou, Haojie Jin, Jingjing Wan, Yongchun Yu, Jiayi Wang, Kun Qian, Lin Huang |
| Bioinｆormatics-based discovery of the involvement of PSAT1 in mediating the anti-lung adenocarcinoma activity of triptolide | 10.1002/ame2.70120 | 2026-01-15 | Animal Models and Experimental Medicine | 3.4 | Zhiwen Cao, Lulu Zhang, Wenqiang Zhang, Rong Wan, Xiaogang Peng, Jinyan Xie, Ruru Bai, Jiejing Jin, Changqi Shi, Lan Yan, Xiangyu Guo, Yang Shen, Cheng Lu |
| Norcantharidin inhibits the EZH2-mediated JAK2/STAT3 signaling pathway to inhibit the proliferation of non-small cell lung cancer | 10.1016/j.taap.2026.117714 | 2026-01-09 | TOXICOLOGY AND APPLIED PHARMACOLOGY | 3.4 | Shuang Wu, Wei Zhang |
| Baricitinib alleviates myositis-associated interstitial lung disease in mice by inhibiting the NETs-cGAS-STING-EMT axis | 10.1016/j.intimp.2025.116137 | 2026-01-01 | INTERNATIONAL IMMUNOPHARMACOLOGY | 4.7 | Jin Guo, Qiyan Su, Hui Chai, Xi Cui, Jiarui Zhu, Jumei Yang, Sigong Zhang |
| HHIPL2 positively governs Hedgehog signaling to accelerate non-small cell lung cancer progression via enhancing HNRNPC-mediated HNF1A mRNA stabilization | 10.1038/s41419-025-08331-3 | 2025-12-18 | Cell Death & Disease | 9.6 | Mu Ning, Liu Fanrong, Song Xiangqing, Wang Biao, Zhu Yilin, Li Lingbing, Yang Lingxiao, Sui Huacong, Wang Jinfu, Gao Fengyuan, Zhou Yongjia, Lv Yanfeng, Tian Zhongxian, Li Peichao, Zhao Xiaogang |
| Glycyrrhizic Acid-based Amorphous Networked Nanomaterial Co-encapsulating Curcumin and IR-813: Overcoming the Limitations of Curcumin Through Precise Targeting and pH-responsive Drug Delivery | 10.1007/s12668-025-02329-z | 2025-12-17 | BioNanoScience | 3.2 | Cai Shuaishuai, Hu Jianpeng, Fang Yicheng, Su Pei, Xue Bo, Jin Guofan |
| DNMT3b promotes proliferation and invasion by mediating HOPX DNA methylation in lung cancer | 10.1016/j.isci.2025.114347 | 2025-12-04 | iScience | 4.1 | Kelei Guan, Songfeng Zhao, Guizhen Zhang, Yun Wang, Dongdong Song, Yanxia Ding |
| Lipid Droplets-Targeted Thermally Activated Delayed Fluorescence Photosensitizer for Photodynamic Therapy-Mediated Ferroptosis: a New Strategy for Tumor Radiosensitization | 10.1002/adhm.202504496 | 2025-11-26 | Advanced Healthcare Materials | 9.6 | Shengnan Xu, Xiang Wang, Keru Pu, Tianxin Liu, Jinli Pei, Xinzhi Zhao, Jinming Yu, Jie Liu, Hai-Yu Hu |
| Organoid-based two-step drug screening for rapid identification of chemotherapy-resistant oesophageal squamous cell carcinoma and alternative therapies | 10.1002/ctm2.70534 | 2025-11-20 | Clinical and Translational Medicine | 6.8 | Chen-Ye Shao, Sheng Ju, Xin Tong, Kang Hu, Yu Li, Yi-xian Zhu, Jian Yang, Chang Li, Yu-feng Xie, Yuan Cui, Wei-jun Deng, Cheng Ding, Song-bing Qin, Jun Zhao |
| Protective effects of Notoginsenoside R1 on the ferroptosis of a human non‑small cell lung cancer cell line | 10.3892/mmr.2025.13742 | 2025-11-06 | Molecular Medicine Reports | 3.5 | Yuejiao Zhang, Zhongshun Mao, Yong Diao |
| A 4‑cuproptosis‑related lncRNA theragnostic signature predicts survival and immunotherapy response in patients with lung adenocarcinoma | 10.3892/mco.2025.2912 | 2025-10-30 | Molecular and Clinical Oncology | 1.4 | Lina Lu, Yinyin Qin, Mingdeng Wang, Yanjun Deng, Yuansheng Lin |
| Biｍmbedllic Ru(II)-Ru(II) complex as an effective non-small cell lung cancer photosensitizer with potential ferroptosis photoinduction | 10.1039/D5DT01430A | 2025-10-20 | DALTON TRANSACTIONS | 3.3 | Feng Chen, Kelun Cui, Yuqing Wei, Sufen Si, Qiu-Yun Chen, Gaoji Wang, Songlin Xue, Yue Wang, Chunyin Zhu |
| A pathological role of O-GlcNAcylation-driven TR11B production and function in lung adenocarcinoma | 10.1016/j.devcel.2025.08.010 | 2025-09-09 | DEVELOPMENTAL CELL | 8.7 | Shiyu Qiu, Lifang Ma, Keke Yu, Xin Xu, Xiao Zhang, Wenjun Yu, Kai Wang, Xiaoting Tian, Yayou Miao, Yikun Wang, Wanxin Guo, Xiangfei Xue, Jiangtao Cui, Xuewen Yu, Rui Kang, Qianjun Zhou, Yongchun Yu, Daolin Tang, Jiayi Wang |
| Characterization of the Chemical Composition, Cytotoxicity, and Metabolomic Effects of PM2.5 in a Plateau City, China | 10.3390/toxics13090729 | 2025-08-29 | Toxics | 4.1 | Mengying Li, Lijuan Qi, Xinyi Xu, Rong Zhao, Xiaotong Wang, Yanhui Ha, Zhe Lin, Sujin Lu, Rong Chen, Junchao Zhao |
| IGF2BP1-mediated methylation of ABCA1 facilitates tumor progression by affecting cholesterol ｍmbedbolism in lung adenocarcinoma | 10.1007/s00726-025-03474-1 | 2025-08-22 | AMINO ACIDS | 2.4 | Xu Shaohua, Liu Kai, Chen Zhao, Tang Weijian, Chen Zhoumiao |
| Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression | 10.1080/21505594.2025.2548626 | 2025-08-18 | Virulence | 5.4 | Guomeng Sha, Zhengwen Wu, Biao Wang, Yi Ding, Zhaohua Xiao, Wenhao Zhang, Jie Zhou, Yongjia Zhou, Guanhong Ji, Zhongxian Tian, Weiquan Zhang, Xiaogang Zhao |
| ZEB1 Contributes to Drug Resistance Through Canonical Wnt Signaling in Lung Cancer | 10.1002/iub.70053 | 2025-08-12 | IUBMB LIFE | 3.2 | Hubo Shi, Min Wang, Qianqian Zhao, Yihui Xu |
| The Synergic Inhibition of Wilforlide A With Cisplatin in Lung Cancer Is Mediated Through Caspase-3 and NFκB Signaling | 10.1002/iub.70043 | 2025-07-30 | IUBMB LIFE | 3.2 | Zhonglu Peng, Xiang Xiao, Xinyi Lu, Dong Cao, Huilong Fang, Zhiying Yang, Dongyang He |
| Dihydroartemisinin inhibits NSCLC by targeting MDM2/c-Myc axis independent of p53 | 10.1016/j.bcp.2025.117191 | 2025-07-26 | BIOCHEMICAL PHARMACOLOGY | 5.6 | Huijuan Ling, Jing Tang, Yayu Zhu, Ke Niu, Ping Qiu, Renjie Chen, Liwen Chen |
| UBE2N inhibition abrogates cancer chemoresistance and ｍmbedstasis in lung adenocarcinoma | 10.1038/s41417-025-00929-1 | 2025-06-22 | CANCER GENE THERAPY | 5.0 | Peng Zi-Mei, Xiong Jin-Yong, Deng Feng-Yi, Wang Xing, Wang Tao, Yang Chun-Xi, Chen Yan-Ru, Han Xiao-Jian, Zhang Zhen |
| Intranasal delivery of platelet cell membrane-cloaked Astragaloside IV loaded biomimetic nanoparticles for enhanced therapeutics in acute lung injury mice | 10.1016/j.ejpb.2025.114777 | 2025-06-08 | EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 4.3 | Yue Zhao, Yinlian Yao, Shilong Fan, Xin Shen, Jiahao Liu, Xingxing Chai, Xueqin Huang, Hua Jin, Zhikun Zhou |
| Exosomal delivery of AZD5582 to overcome TRAIL resistance as an optimal therapy against triple-negative breast cancer | 10.1016/j.acthis.2025.152270 | 2025-05-24 | ACTA HISTOCHEMICA | 2.4 | Wanting Zhang, Quanjiang Li, Rui Tian, Zhujie Deng, Ronghui Sun, Xiubin Kuang, Jun Peng, Bin Xie, Chen Huang, Zhengqiang Yuan |
| Ticagrelor inhibits the growth of lung adenocarcinoma by downregulating SYK expression and modulating the PI3K/AKT pathway | 10.1038/s41598-025-02721-5 | 2025-05-20 | Scientific Reports | 3.9 | Song Yuanhong, He Suwei, Zeng Lanhui, He Yuanqiao, Huang Ling |
| Mitochondrial CCN1 drives ferroptosis via fatty acid β-oxidation | 10.1016/j.devcel.2025.04.004 | 2025-04-24 | DEVELOPMENTAL CELL | 8.7 | Wanxin Guo, Congcong Zhang, Qianjun Zhou, Tianxiang Chen, Xin Xu, Jianfeng Zhang, Xuewen Yu, Han Wu, Xiao Zhang, Lifang Ma, Kun Qian, Daniel J. Klionsky, Rui Kang, Guido Kroemer, Yongchun Yu, Daolin Tang, Jiayi Wang |
| TRIM6 Promotes Cell Cycle and Growth by Modulating p53 Signaling Pathway in Lung Adenocarcinoma | 10.2147/IJGM.S497383 | 2025-04-12 | International Journal of General Medicine | 2.0 | Xi Lu, Haifeng Wang, Tingting Yu |
| Development of an alkaliptosis-related lncRNA risk model and immunotherapy target analysis in lung adenocarcinoma | 10.3389/fgene.2025.1573480 | 2025-04-08 | Frontiers in Genetics | 2.8 | Xiang Xiong, Wen Liu, Chuan Yao* |
| Tumor-derived immunoglobulin-like tranｓcript 3 inhibition reshapes the immunosuppressive tumor microenvironment and potentiates programmed cell death ligand 1 blockade immunotherapy in lung adenocarcinoma | 10.1016/j.tranon.2025.102381 | 2025-04-08 | Translational Oncology | 4.1 | Leirong Wang, Qing Li, Yanxin Sun, Shuyun Wang, Xuebing Fu, Xiufen Wang, Yan Zheng, Aiqin Gao, Yuping Sun, Juan Li |
| Mechanism of astragaloside A against lung adenocarcinoma based on network pharmacology combined with molecular dynamics simulation technique | 10.1038/s41598-025-94793-6 | 2025-04-08 | Scientific Reports | 3.9 | Ding Jian, Xue Qian, Guo Weizhen, Cheng Gang, Zhang Lu, Huang Tantan, Wu Di, Tong Jiabing, Yang Cheng, Gao Yating, Li Zegeng |
| Significance of Ribonucleoside-diphosphate Reductase Subunit M2 in Lung Adenocarcinoma | 10.2174/0115665232286359240611051307 | 2025-04-01 | CURRENT GENE THERAPY | 3.3 | Xiao-Jun Wang, Yun-Xia Huo, Peng-Jun Yang, Jing Gao, Wei-Dong Hu |
| Pirfenidone alleviates interstitial lung disease in mice by inhibiting neutrophil extracellular trap ｆormation and NLRP3 inflammasome activation | 10.1093/cei/uxaf019 | 2025-03-21 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 3.8 | Su Qiyan, Feng Yingyue, Guo Jin, Cui Xi, Zhu Jiarui, Yang Jumei, Zhang Sigong |
| A prognostic model for lung adenocarcinoma based on cuproptosis and disulfidptosis related genes revealing the key prognostic role of FURIN | 10.1038/s41598-025-90653-5 | 2025-02-19 | Scientific Reports | 3.9 | You Jianhang, Yu Qing, Chen Ronghui, Li Jianlin, Zhao Tao, Lu Zhong |
| 3,5,6,7,8,3’,4’- Heptamethoxyflavonoid inhibits TGF-β1-induced epithelial–mesenchymal transition by regulating oxidative stress and autophagy through MEK/ERK/PI3K/AKT/mTOR signaling pathway | 10.1038/s41598-025-88869-6 | 2025-02-07 | Scientific Reports | 3.9 | Wang Yiting, Ma Zhiheng, Peng Weiwen, Yu Qinglian, Liang Wenjie, Cao Liu, Wang Zhuqiang |
| cGAS-STING mediates neutrophil extracellular traps-induced EMT in myositis-associated interstitial lung disease: STING as a potential therapeutic target | 10.1016/j.intimp.2025.114144 | 2025-02-03 | INTERNATIONAL IMMUNOPHARMACOLOGY | 4.7 | Yingyue Feng, Qiyan Su, Jiarui Zhu, Xi Cui, Jin Guo, Jumei Yang, Sigong Zhang |
| Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinｆormatic analysis and experimental validation | 10.1186/s12885-024-13415-y | 2025-01-10 | BMC CANCER | 3.4 | Wang Zihan, Cui Wenjing, Liang Long, Qu Jingge, Pei Yuqiang, Li Danyang, Luo Ying, Zhang Yue, Qiu Yifan, Sun Yongchang |
| Low-dose radiation ameliorates PM2.5-induced lung injury through non-canonical TLR1/TLR2-like receptor pathways modulated by Akkermansia muciniphila | 10.1016/j.ecoenv.2024.117625 | 2025-01-02 | ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY | 6.1 | Li Wang, Zhipeng Li, Huan He, Lijing Qin, Weiqiang Xu, Hongyuan Tian, Rongrong Liu, Xinru Lian, Wen Li, Yali Qi, Zhicheng Wang |
| Enhancing Student Comprehension of Glucose Metabolism Visualization Through Virtual Simulation Platｆorm: An Educational Approach | 10.1002/prp2.70042 | 2024-11-27 | Pharmacology Research & Perspectives | 2.9 | Luna Ge, Tingting Feng, Shuo Cao, Hang Yin, Yuang Zhang, Jihong Pan, Wei Chen, Kai Cheng, Lin Wang |
| A novel mouse model of myositis-associated interstitial lung disease was established by using TLR9 agonist combined with muscle homogenate | 10.1093/cei/uxae106 | 2024-11-22 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 3.4 | Bai Ling, Zhu Jiarui, Ma Wenlan, Zhao Peipei, Li Feifei, Zhang Cen, Zhang Sigong |
| Exploring a new signature for lung adenocarcinoma: analyzing cuproptosis-related genes through Integrated single-cell and bulk RNA sequencing | 10.1007/s12672-024-01389-z | 2024-09-29 | Discover Oncology | 2.8 | Liu Jiangtao, Xia Wei, Xue Feng, Xu Chen |
| Downregulation of the m6A reader YTHDC2 upregulates exosome content in lung adenocarcinoma via inhibiting IFIT and OAS family members | 10.1016/j.jbc.2024.107783 | 2024-09-18 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4.0 | Zhixin Yin, Lifang Ma, Xiaoting Tian, Qi Sun, Congcong Zhang, Yikun Wang, Yayou Miao, Xiangfei Xue, Yongjie Wang, Jiayi Wang, Xiao Zhang, Xumin Hou |
| PKHD1L1 blocks the malignant behavior of lung adenocarcinoma cells and restricts tumor growth by regulating CBX7 | 10.32604/biocell.2024.049626 | 2024-08-02 | BIOCELL | 0.8 | KEWEI CHENG, LEI SHI, CAIWEN SHI, SHUANSHUAN XIE, CHANGHUI WANG |
| Prognostic and immunotherapeutic significances of M2 macrophage-related genes signature in lung cancer | 10.7150/jca.98044 | 2024-07-22 | Journal of Cancer | 3.3 | Wu Haixia, Yu Yilin, Wang Wei, Lin Gen, Lin Shaolin, Zhang Jiguang, Yu Zhaojun, Luo Jiewei, Ye Deju, Chi Wu, Lin Xing |
| Vitamin D Binding Protein: A Potential Factor in Geriatric COVID-19 Acute Lung Injury | 10.2147/JIR.S470097 | 2024-07-07 | Journal of Inflammation Research | 4.2 | Hongjuan Jiang, Xiangyu Chi, Yanhong Sun, Hongwen Li |
| Identification of oxidative stress signatures of lung adenocarcinoma and prediction of patient prognosis or treatment response with single-cell RNA sequencing and bulk RNA sequencing data | 10.1016/j.intimp.2024.112495 | 2024-06-19 | INTERNATIONAL IMMUNOPHARMACOLOGY | 4.8 | Yunchi Yu, Miaoyan Liu, Zihang Wang, Yufan Liu, Min Yao, Li Wang, Lou Zhong |
| CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis | 10.1186/s12967-024-05284⁻⁷ | 2024-05-15 | Journal of Translational Medicine | 6.1 | Shao-Kun Yu, Tao Yu, Yu-Ming Wang, Ao Sun, Jia Liu, Kai-Hua Lu |
| Gefitinib ｍmbedbolism-related lncRNAs for the prediction of prognosis, tumor microenvironment and drug sensitivity in lung adenocarcinoma | 10.1038/s41598-024-61175-3 | 2024-05-06 | Scientific Reports | 3.8 | Guo Zishun, Zhang Xin, Yang Dingtao, Hu Zhuozheng, Wu Jiajun, Zhou Weijun, Wu Shuoming, Zhang Wenxiong |
| CacyBP promotes the development of lung adenocarcinoma by regulating OTUD5 | 10.1093/carcin/bgae023 | 2024-04-01 | CARCINOGENESIS | 3.3 | Bai Mixue, Lu Kun, Che Yingying, Fu Lin |
| Synergistic effect of cannabidiol with dasatinib on lung cancer by SRC/PI3K/AKT signal pathway | 10.1016/j.biopha.2024.116445 | 2024-03-18 | BIOMEDICINE & PHARMACOTHERAPY | 6.9 | Qianqian Ye, Changqin Gui, Di Jin, Jiazhen Zhang, Jing Zhang, Na Ma, Li Xu |
| Usenamine A triggers NLRP3/caspase-1/GSDMD-mediated pyroptosis in lung adenocarcinoma by targeting the DDX3X/SQSTM1 axis | 10.18632/aging.205450 | 2024-01-23 | Aging-US | 3.9 | Min Li, Rongrong Wu, Le Wang, Dongyi Zhu, Shinan Liu, Ruolan Wang, Chaowen Deng, Shenglin Zhang, Min Chen, Ruojin Lu, Hongxing Zhu, Mengting Mo, Xiaoqiong He, Zhuang Luo |
| Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression | 10.1186/s12931-023-02566-4 | 2023-11-12 | RESPIRATORY RESEARCH | 5.8 | Zhou Jie, Li Peiwei, Zhao Xiaogang, Zhao Yuanhao, Luo Junwen, Deng Yupeng, Jiang Ning, Xiao Zhaohua, Zhang Wenhao, Zhou Yongjia, Zhao Jiangfeng, Li Peichao, Li Yuliang, Tian Zhongxian |
| EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis | 10.1007/s11239-023-02916-5 | 2023-11-08 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 4.0 | Su Yanping, Yi Jiawen, Zhang Yuan, Leng Dong, Huang Xiaoxi, Shi Xinyu, Zhang Yuhui |
| Intensity Interrogation-Based High-Sensitivity Surface Plasmon Resonance Imaging Biosensor for Apoptosis Detection in Cancer | 10.3390/bios13100946 | 2023-10-23 | Biosensors-Basel | 5.4 | Xin Yuan, Zhenxiao Niu, Lang Liu, Youjun Zeng, Lin Ma, Zhaogang Nie, Zhen Tian, Dongyun Kai, Fangteng Zhang, Guanyu Liu, Siwei Li, Zhengqiang Yuan |
| Nickel chloride promotes lung cancer invasion and ｍmbedstasis by up-regulating the expression of E3 ubiquitin ligase TRIM31 through the IL-6/STAT3 signaling axis | 10.1016/j.lfs.2023.122111 | 2023-09-19 | LIFE SCIENCES | 6.1 | Yongbin Lu, Fei Su, Zhiyuan Cheng, Jingli Yang, Huanyu Dai, Jingru Yang, Tao Zhang, Yana Bai |
| System analysis based on glutamine catabolic-related enzymes identifies GPT2 as a novel immunotherapy target for lung adenocarcinoma | 10.1016/j.compbiomed.2023.107415 | 2023-08-29 | COMPUTERS IN BIOLOGY AND MEDICINE | 7.7 | Bolin Wang, Jinli Pei, Shengnan Xu, Jie Liu, Jinming Yu |
| Construction and validation of an efferocytosis-related prognostic signature in lung adenocarcinoma | 10.1007/s00432-023-05251⁻⁷ | 2023-08-14 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 3.6 | Liu Jian, Wei Li |
| Screening and validation of plasma cell-derived, purinergic, and calcium signalling-related genetic signature to predict prognosis and PD-L1/PD-1 blockade responses in lung adenocarcinoma | 10.1007/s00432-023-05153-8 | 2023-07-19 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 3.6 | Huang Junfeng, Fan Xingyu, Hu Bingqi, Chen Liwen |
| Study on the material basis and action mechanisms of sophora davidii (Franch.) skeels flower extract in the treatment of non-small cell lung cancer | 10.1016/j.jep.2023.116815 | 2023-07-01 | JOURNAL OF ETHNOPHARMACOLOGY | 5.4 | Baibai Ye, Ping Chen, Cheng Lin, Chenning Zhang, Linfu Li |
| N-linoleyltyrosine resisted the growth of non-small cell lung cancer cells via the regulation of CB1 and CB2 involvement of PI3K and ERK pathways | 10.3389/fphar.2023.1164367 | 2023-06-08 | Frontiers in Pharmacology | 5.6 | Hu Yan, Zhao Zhe, Liu Yuan-Ting, Xu Ze-Cheng, Li Jing-Yi, Yang Zheng-Yu, Rui-Wang , Yang Yun-Qi, Zhang Jia-Hui, Qiu Si-Yuan, He Tao, Wu Yi-Ying, Liu Sha |
| Bufalin inhibits the proliferation of lung cancer cells by suppressing Hippo-YAP pathway | 10.1016/j.cellsig.2023.110746 | 2023-06-05 | CELLULAR SIGNALLING | 4.8 | Zijun Qian, Xiaoting Tian, Yayou Miao, Xin Xu, Xuehua Cheng, Mengyi Wu, Yongchun Yu |
| LPCAT3 is tranｓcriptionally regulated by YAP/ZEB/EP300 and collaborates with ACSL4 and YAP to determine ferroptosis sensitivity | 10.1089/ars.2023.0237 | 2023-05-11 | ANTIOXIDANTS & REDOX SIGNALING | 6.6 | Mr. Jiangtao Cui, Dr. Yikun Wang, Ms. Xiaoting Tian, Ms. Yayou Miao, Prof. Lifang Ma, Ms. Congcong Zhang, Dr. Xin Xu, Dr. Jiayi Wang, Prof. Wentao Fang, Prof. Xiao Zhang |
| Tumor-expressed B7-H3 promotes vasculogenic mimicry ｆormation rather than angiogenesis in non-small cell lung cancer | 10.1007/s00432-023-04790-3 | 2023-05-02 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 3.6 | Fan Xingyu, Huang Junfeng, Hu Bingqi, Zhou Jing, Chen Liwen |
| In vitro and in vivo study on the treatment of non-small cell lung cancer with radionuclide labeled PD-L1 nanobody | 10.1007/s00432-023-04793-0 | 2023-04-21 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 3.6 | Zhu Mengqin, Zhang Jiajia, Yang Mengdie, Zhang Han, Xu Tao, Kan Fei, Zhang Xiaoyi, Zhang Shenghong, Yin Yuzhen, Yu Fei |
| Jie Geng Tang reverses cisplatin resistance through the Nrf2 pathway in lung canc |
热门标签：人肺癌细胞,A549,A549细胞·
